DNA immunization using highly conserved murine cytomegalovirus genes encoding homologs of human cytomegalovirus UL54 (DNA polymerase) and UL105 (helicase) elicits strong CD8 T-cell responses and is protective against systemic challenge.
about
Cytomegalovirus vaccine developmentImprovement of cytomegalovirus pp65 DNA vaccine efficacy by co-administration of siRNAs targeting BAK and BAXComparison of multiple DNA vaccines for protection against cytomegalovirus infection in BALB/c mice.Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 diseaseDevelopment of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccineAn adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMVComplete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gOIdentification of an atypical CD8 T cell epitope encoded by murine cytomegalovirus ORF-M54 gaining dominance after deletion of the immunodominant antiviral CD8 T cell specificities.Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance.A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus.25-Hydroxycholesterol activates the integrated stress response to reprogram transcription and translation in macrophages.Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?Cytomegalovirus infection and progressive differentiation of effector-memory T cells
P2860
Q33702990-6C2FAA1A-7749-469C-B6DE-FEC7AABF924BQ33744024-AC27BE1E-32DB-4783-9138-8558140D783FQ33813837-42E34849-4497-4660-A9FD-4A9E888D1557Q34742583-0CAEA3CC-CEDE-4EDD-9204-09DB7CEB5C90Q34788895-185C2F68-4E07-4A7A-B279-AE6EFC3FC5D6Q35144633-70D97669-7641-416E-A7D3-A33297E167D3Q35214272-83658430-ED26-45CD-8AD9-AC15C8CE2792Q35585875-D53D9252-A9CD-48DB-BFAA-AB7A559671A3Q36673260-2B4ABF02-DEF3-4F71-BE2E-BE37F937A205Q36999665-44FFEB03-43F9-4C8D-858A-ED3D75583B77Q37355242-BC44BAB0-953D-43F4-B8AC-EE20F7EB763EQ37388798-53B49E5E-B5AC-4425-8061-58436498E175Q37559627-79B0C2E0-1CA1-419C-B8E0-209B5CAF6833Q37574334-2E13D38D-500C-4412-BE3D-7BE0717B0D3DQ57821275-B488A73A-9198-4CBE-808F-2D0BC8AD2C3B
P2860
DNA immunization using highly conserved murine cytomegalovirus genes encoding homologs of human cytomegalovirus UL54 (DNA polymerase) and UL105 (helicase) elicits strong CD8 T-cell responses and is protective against systemic challenge.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
DNA immunization using highly ...... ve against systemic challenge.
@ast
DNA immunization using highly ...... ve against systemic challenge.
@en
type
label
DNA immunization using highly ...... ve against systemic challenge.
@ast
DNA immunization using highly ...... ve against systemic challenge.
@en
prefLabel
DNA immunization using highly ...... ve against systemic challenge.
@ast
DNA immunization using highly ...... ve against systemic challenge.
@en
P2093
P2860
P356
P1433
P1476
DNA immunization using highly ...... ive against systemic challenge
@en
P2093
Ann B Hill
Christopher S Morello
Laura A Kelley
Michael W Munks
P2860
P304
P356
10.1128/JVI.00633-07
P407
P577
2007-05-16T00:00:00Z